Bangkok Lab And Cosmetic PCL (BKK: BLC)

Market Cap	3.18B
Revenue (ttm)	1.55B
Net Income (ttm)	166.85M
Shares Out	600.00M
EPS (ttm)	0.28
PE Ratio	19.06
Forward PE	n/a
Dividend	0.14 (2.64%)
Ex-Dividend Date	Aug 27, 2024

Volume	4,172,284
Open	5.30
Previous Close	5.30
Day's Range	5.10 - 5.30
52-Week Range	4.00 - 6.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About BLC

Bangkok Lab And Cosmetic Public Company Limited manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. The company distributes food supplements, cosmeceuticals, and pharmaceutical drugs; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. It also engages in provision of management consulting and logistic services; and export of cosmeceuticals, pharmaceutical drugs, medicines, herbs...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2022
• Employees: 947
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BLC

Financial Performance

In 2023, BLC's revenue was 1.42 billion, an increase of 14.11% compared to the previous year's 1.24 billion. Earnings were 145.39 million, an increase of 15.65%.